
1. virology. 2012 jan 20;422(2):242-53. doi: 10.1016/j.virol.2011.10.027. epub 2011 
nov 17.

the human papillomavirus type 16 e7 oncoprotein targets myc-interacting
zinc-finger protein-1.

morandell d(1), kaiser a, herold s, rostek u, lechner s, mitterberger mc,
jansen-dürr p, eilers m, zwerschke w.

author information: 
(1)cell metabolism differentiation research group, institute biomedical
aging research austrian academy sciences, innsbruck, austria.

we demonstrate hpv-16 e7 forms complex miz-1. uv-induced expression
of cdk-inhibitor p21(cip1) subsequent cell cycle arrest depends upon
endogenous miz-1 hpv-negative c33a cervical cancer cells containing mutated
p53. transient expression e7 c33a inhibits uv-induced expression of
p21(cip1) overcomes miz-1-induced g1-phase arrest. c-terminal
e7δ79ledll83-mutant reduced miz-1-binding capacity impaired its
capability repress p21(cip1) expression; whereas prb-binding-deficient
e7c24g-mutant inhibited p21(cip1) expression similar wild-type e7. using chip,
we demonstrate endogenous e7 bound endogenous p21(cip1)
core-promoter caski cells rnai-mediated knock miz-1 abrogates
e7-binding p21(cip1) promoter. co-expression e7 miz-1 inhibited
miz-1-induced p21(cip1) expression minimal-promoter via miz-1
dna-binding sites. co-expression e7δ79ledll83 inhibit miz-1-induced
p21(cip1) expression. e7c24g retained e7-wild-type capability inhibit
miz-1-dependent transactivation. findings suggest hpv-16 e7 can
repress miz-1-induced p21(cip1) gene expression.

copyright © 2011 elsevier inc. rights reserved.

doi: 10.1016/j.virol.2011.10.027 
pmcid: pmc3268862
pmid: 22099967  [indexed medline]

